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ARTICLE OPEN
Characterisation of antibiotic prescriptions for acute
respiratory tract infections in Danish general practice: a
retrospective registry based cohort study
Rune Aabenhus 1, Malene Plejdrup Hansen1,2, Laura Trolle Saust1,3 and Lars Bjerrum1
Inappropriate use of antibiotics is contributing to the increasing rates of antimicrobial resistance. Several Danish guidelines on
antibiotic prescribing for acute respiratory tract infections in general practice have been issued to promote rational prescribing of
antibiotics, however it is unclear if these recommendations are followed. We aimed to characterise the pattern of antibiotic
prescriptions for patients diagnosed with acute respiratory tract infections, by means of electronic prescriptions, labeled with
clinical indications, from Danish general practice. Acute respiratory tract infections accounted for 456,532 antibiotic prescriptions
issued between July 2012 and June 2013. Pneumonia was the most common indication with 178,354 prescriptions (39%), followed
by acute tonsillitis (21%) and acute otitis media (19%). In total, penicillin V accounted for 58% of all prescriptions, followed by
macrolides (18%) and amoxicillin (15%). The use of second-line agents increased with age for all indications, and comprised more
than 40% of the prescriptions in patients aged >75 years. Women were more often prescribed antibiotics regardless of clinical
indication. This is the ﬁrst Danish study to characterise antibiotic prescription patterns for acute respiratory tract infections by data
linkage of clinical indications. The ﬁndings conﬁrm that penicillin V is the most commonly prescribed antibiotic agent for treatment
of patients with an acute respiratory tract infection in Danish general practice. However, second-line agents like macrolides and
amoxicillin with or without clavulanic acid are overused. Strategies to improve the quality of antibiotic prescribing especially for
pneumonia, acute otitis media and acute rhinosinusitis are warranted.
npj Primary Care Respiratory Medicine  (2017) 27:37 ; doi:10.1038/s41533-017-0037-7
INTRODUCTION
Antimicrobial resistance rates have reached alarming levels and
presently constitute a serious public health concern by threaten-
ing one of the most effective and mortality lowering interventions
in modern medicine.1 Part of the solution to this problem includes
minimizing overuse of antibiotics as they are directly linked to the
development of antimicrobial resistance.2 As a consequence, it is
imperative we make judicious use of the available antibiotics in
order to maintain their effectiveness in the years ahead.
Acute respiratory tract infections are common reasons for
consulting in general practice and assumed responsible for more
than 60% of the antibiotic use in this setting.3 But the effect of
antibiotic treatment, when pneumonia is not suspected, is at best
moderate,4–6 indicating that a large amount of antibiotic
prescriptions are in fact inappropriate and confer no net beneﬁt
for the patient. Strategies, such as guidelines on rational antibiotic
use, as well as educational and decision support systems are
applied to improve antibiotic prescribing. However, the imple-
mentation of these strategies into daily clinical routine can be
difﬁcult and daily practice is far from optimal7, 8 in turn
augmenting the risk of inappropriate prescribing both in regard
to quantity (e.g., overprescribing) and quality (e.g., non-optimal
choice of antibiotic).9
As antibiotic resistance rates are low in Denmark10 National
Guidelines11 on antibiotic prescribing for acute respiratory tract
infections recommend narrow-spectrum penicillin (penicillin V) as
ﬁrst-line agent for acute respiratory infections, except acute
exacerbations of chronic obstructive pulmonary disease (AECOPD)
where the recommendation was amoxicillin with clavulanic acid
(co-amoxicillin).
In Denmark, previous attempts to assess current prescribing
practice for speciﬁc infections have been based on small subsets
of general practitioners that volunteered to participate for a
limited time.12
Surveillance of antibiotic prescribing and consumption is a
central element in containing the increasing antimicrobial
resistance.9, 13 Patterns of antibiotic prescriptions, particularly
when linked to clinical indications and patient demographics, can
be helpful in determining appropriateness of the issued prescrib-
ing: lately results from the UK and the Netherlands have
successfully applied data linkage to characterise prescribing of
ﬂucloxacillin and analyze trends in prescribing for sore throat,
colds, and acute cough.14–16
To promote rational antibiotic use in Denmark, and study the
link between clinical indications and the associated antibiotic
prescribing, an electronic system with mandatory data entry of
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clinical indications for antibiotic prescribing was introduced in
2011.
We aimed to characterise the pattern of antibiotic prescriptions
for acute respiratory tract infections, by means of clinical
indications from electronic prescriptions, in regard to national
guidelines on antibiotic prescribing in Danish general practice.
RESULTS
Clinical indications for antibiotic prescribing
A total of 2.4 million systemic antibiotic prescriptions (ATC J01)
corresponding to 424 treatments per 1000 inhabitants were
issued in the 1-year study period. A clinical indication was
assigned in 1.6 million prescriptions, however about 25% (416,355)
of the prescriptions did not include a speciﬁc clinical indication,
but only stated e.g. “against infection”. Acute respiratory tract
infections accounted for 456,532 prescriptions, of which pneu-
monia accounted for 178,354 (39%), followed by tonsillitis (N =
96.549; 21%), acute otitis media (AOM, N = 87.064; 19%), acute
rhinosinusitis (N = 81.662; 18%), AECOPD (N = 9967; 2%), and acute
bronchitis (N = 2.935; 1%) (Table 1).
Women were more often prescribed antibiotics regardless of
clinical indication (female:male ratio 1.33; 95% conﬁdence interval
(CI) 1.32–1.34). Notably, women were prescribed antibiotics twice
as often as men (female:male ratio 2.18; 95% CI 2.14–2.21) in acute
rhinosinusitis.
Marked variations were found in relation to age (Fig. 1).
Prescribing for AOM and pneumonia was high in children under 5
years of age (total exposure for acute respiratory infection was 244
treatments per 1000 inhabitants less than 5 years). Middle-aged
adults were more commonly prescribed antibiotics for acute
rhinosinusitis and tonsillitis, yet exposure in this group (15–74
years) was low with a range between 65 to 80 treatments per 1000
inhabitants. The clinical indication in older adults (>75 years) was
predominantly pneumonia and exposure to antibiotics for
respiratory tract infection was high (264 treatments per 1000
inhabitants).
Patterns of antibiotic prescriptions
In total, penicillin V accounted for 57.7% of all prescriptions;
macrolides second (18%) and amoxicillin third (15%). Quinolone
and tetracycline use were low. Antibiotic use patterns differed
between the individual clinical indications (Table 1). Penicillin V
use was highest in acute tonsillitis (86%), in contrast to acute
bronchitis where only 0.4% of prescriptions were penicillin V.
Macrolide use was highest in acute bronchitis (55.7%) and
pneumonia (27.3%). Co-amoxicillin comprised 86% of the total
antibiotic use in patients diagnosed with AECOPD, but was also
prescribed to one in seven diagnosed with pneumonia. Use of
amoxicillin was higher than penicillin V among children aged less
than 5 years: AOM (56% vs. 39%); acute rhinosinusitis (75% vs.
20%); pneumonia (48% vs. 43%) but not in acute tonsillitis (26% vs.
70%) (Figs. 2–5).
From 5 years and up, the use of second-line agents increased
with age for all respiratory indications, and more than 50% of the
prescriptions comprised second-line agents in patients aged >75
years. The clinical indication acute tonsillitis was the only
indication with a relatively high proportion of penicillin V among
the elderly (Figs. 2–5).
Antibiotic prescriptions in regard to guidelines on antibiotic
prescribing
Overall penicillin V use was less than expected according to our
predetermined criteria of at least 80% ﬁrst-line agents (Table 1).
However, in children under the age of 5 years, more than 90% of
prescriptions comprised penicillin V or amoxicillin. T
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We found that 30.0% of prescriptions for AOM were administered
to children younger than 2 years of age, and 50.9% before age 5
years (Figs. 1 and 2). In acute tonsillitis, prescribing in toddlers
younger than 3 years of age occurred in 6.6% (Figs. 1 and 3).
Similarly, antibiotics were infrequently prescribed in children with
acute rhinosinusitis under the age of 5 years (1.1%) and under the
age of 15 years (3.4%) (Figs. 1 and 4).
DISCUSSION
Main ﬁndings
This is the ﬁrst study to link clinical indications to antibiotic
prescribing for acute respiratory tract infections in Danish general
practice.
Based on all prescriptions, pneumonia was the most common
clinical indication (39%), followed by acute tonsillitis (21%), AOM
(19%), and acute rhinosinusitis (18%). The frequency of the clinical
indications showed pronounced associations with age. We found
that penicillin V was the most commonly used antibiotic agent
(58%), macrolides second (18%), and amoxicillin third (15%).
The relative low use of penicillin V is not in line with guidelines
recommendations on acute respiratory tract infections (except
AECOPD) indicating that current prescribing could still be
improved in order to better adhere to Danish guidelines on
antibiotic use. Importantly, we found that the use of second-line
agents including critical macrolides that belong to the WHO-
deﬁned group of antibiotics of the highest priority17 increased,
especially in the older age group. Further efforts are needed to
promote rational antibiotic use in patients with acute respiratory
tract infection, particularly for AOM, acute rhinosinusitis, and
pneumonia.
Interpretation of ﬁndings in relation to previously published work
Few non-Scandinavian countries recommend penicillin V as ﬁrst-
line agent and the European Society for Clinical Microbiology and
Infectious Disease recommend amoxicillin or a tetracycline in
lower respiratory tract infections.18 No clear evidence has pointed
to a speciﬁc antibiotic agent as most effective in empirical
antibiotic therapy.19 As most serious acute respiratory infections
are related to pneumococci, penicillin V may (in the absence of
high resistance rates) be regarded a rational choice due to its high
Fig. 1 Antibiotic use for patients with acute respiratory tract
infections by age
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Fig. 2 Acute otitis media. Prescribing pattern by age group
(N= 87.064)
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Fig. 3 Acute tonsillitis. Prescribing pattern by age group
(N= 95.459)
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Fig. 4 Acute rhinosinusitis. Prescribing pattern by age group
(N= 81.662)
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activity against gram positive cocci (minimal inhibitory concentra-
tion 0.06 µg/ml) 20 and few side effects.
In young children, who for the most part will use syrup or other
liquid formulations of antibiotics, the high use of amoxicillin is also
reported in studies from Norway21 and this is most probable
related to the superior taste of amoxicillin compared to the ﬁrst-
line agent penicillin V. Accordingly, it may be reasonable to
prescribe amoxicillin to secure compliance with treatment,22 also
as recent studies have suggested that resistance selection by
amoxicillin is mostly short-lived (less than 1 month).23 However
the long-term effects and increased risk of resistance24 calls for
caution, and antibiotic prescribing should be targeted to patients
with a high chance of beneﬁt.5, 25
Antibiotic use for patients diagnosed with acute tonsillitis was
predominantly penicillin V (86%),which may be perceived as in
line with national recommendations.11, 26 Furthermore, less than
6% of the antibiotic prescriptions for acute tonsillitis were
administered in children under 3 years, a group having a low a
priori risk of strep throat.27 In Dutch children, the use of ﬁrst-line
treatment with penicillin V in acute tonsillitis was 60%.8 Most
Danish general practitioners (GPs) use point-of-care tests to swab
for the presence of Streptococcus group A antigen as part of the
clinical management of sore throat. Identifying a causable
pathogen may lead to choosing a relevant narrow-spectrum
agent such as penicillin V.
Today, AOM is mostly perceived as a self-limiting disease in
children older than 2 years of age and the modest beneﬁt of
antibiotic treatment has been established.6 Still two-thirds of all
prescriptions are given in children older than 2 years of age and
half in patients aged more than 5 years. This ﬁnding indicates a
possible overuse of antibiotics in patients diagnosed with AOM,
which is a common reason for antibiotic use in children.16
In contrast, age-stratiﬁed antibiotic prescribing in patients
diagnosed with acute rhinosinusitis appeared meaningful as only
3% of prescriptions were issued in children under 15 years of age.
Children do not have fully developed sinuses until adolescence.
However, it is important not to miss this diagnosis due to the risk
of orbital or endo-cranial complications, especially in young
children under 6 years of age.28 In adults, the antibiotic use in
acute sinusitis has previously been assessed as inappropriate as
60% have had less than 5 days of symptoms prior to presentation
and only 30% presented with fever.29
The clinical indication “pneumonia” made up 39% of all
antibiotic prescriptions for acute respiratory tract infections. In
2012, there were 30,000 hospital admissions with pneumonia and
1555 patients died (www.statistikbanken.dk). It has previously
been estimated that the number of patients seen in general
practice was up to ﬁve times greater, which mounts to roughly the
number of clinical indications “pneumonia” the same year
(178.354). This number may however be affected by the limited
available indications in the electronic prescription system (no
clinical indication exists for cold or cough) or due to diagnostic
drift, i.e., that the doctor tends to justify a prescription by labeling
it”pneumonia”.30 Secondly, GPs may have entered a free text
indication or selected an unspeciﬁc term “infection”, as such not
permitting a detailed analysis of the prescribing. Lastly, some
cases of mild pneumonia may not have been prescribed
antibiotics or perhaps the patient never ﬁlled the prescription
(primary non-compliance in Denmark is 6.5% for antibiotic
scripts).31 This may indeed be the case as results from the
European project Happy Audit32 found 17% of acute respiratory
tract infections to be acute bronchitis with an associated antibiotic
prescribing rate of 35%. The striking differences to the national
ﬁgures based on the clinical indications we present in this paper is
problematic, as the current system of electronic prescriptions may
not capture a sufﬁciently detailed picture of antibiotic prescribing.
Generally, we observed a trend towards increasing prescribing
of second-line agents in older age groups. A macrolide is
recommended in case of penicillin allergy; however it does not
seem plausible to ascribe all of observed broad-spectrum use to
penicillin V allergy or penicillin resistant bacteria detected by
microbiological testing. The exact reason for the increase is not
deducible from the present data, but factors involved may include
uncertainties in management and diagnosis, patient preferences
including ease of administration and a difference in the suspected
microbiological etiology of acute respiratory tract infections.
Of note, no mycoplasma epidemic was observed in the winter
2012–2013. Still one in four patients with pneumonia was
prescribed a macrolide. Similar ﬁndings concerning overuse of
second-line agents have been presented from the Netherlands.33
Prescribing of other critical antibiotics of the highest priority,17
namely 3th and 4th generation cephalosporins and quinolones
was low (0,1 and 0.6%). These ﬁndings are in line with the Danish
recommendations stating that these agents should only be
prescribed following microbiological identiﬁcation and known
susceptibility to treatment.34 Moxiﬂoxacin was the main quinolone
prescribed for AECOPD and acute rhinosinusitis, while ciproﬂox-
acin was issued for patients diagnosed with pneumonia or AOM.
The broader the antibiotic spectrum an agent has, the larger the
effect on the intestinal ﬂora. Penicillin V is considered a narrow-
spectrum antibiotic, but most second-line agents have a broader
spectrum of antibacterial activity. Avoidance of inappropriate use
of second-line agents is a requirement to limit harm to the
patients’ normal ﬂora and minimize risk of developing antibiotic
resistance in common bacteria.
Strengths and limitations of the study
The electronic data collection ensured complete and valid routine
data, from GPs not aware of the investigation, making the results
generalizable to other settings.
We did not have data to assess the speciﬁc consultation rates
for acute respiratory tract infections. As a result, we are unable to
compare data on proportion of consultations for acute respiratory
tract infection that resulted in an antibiotic prescription.15 Also,
the number of treatments per age group provided should be
interpreted with caution as missing and unspeciﬁc indications are
not included. However, the total antibiotic use of 424 treatments
per 1000 inhabitants per year can be compared to prescriptions
rates from a Dutch study33 of 45 primary practices with a
prescribing rate of 300 treatments per 1000 patient years. The
Netherlands is a low antibiotic prescribing country and further-
more out-of-hours use was not included.
A substantial number of prescriptions were not available for
analysis due to either no clinical indication present on the
electronic prescriptions or non-speciﬁc indications hampering the
precise assessment of incidences of speciﬁc acute respiratory
infections. However, the remaining large number of data can
provide a valid speciﬁcation of the antibiotic use pattern for
selected clinical indications, as we did not ﬁnd evidence of a
systematic difference regarding patient or provider age and sex in
the overall antibiotic use between scripts with no indications or
unspeciﬁc indications vs. scripts with speciﬁc indications (data not
shown).
A number of clinical indications may be missing from telephone
or handwritten prescriptions. We have no methods to assess this
amount, but we believe this number is relatively small and with no
substantial impact on the antibiotic use pattern.
It may be argued, those GPs who are not up-to-date or who do
not want to be part of surveillance systems could be under-
represented or not coding in a meaningful way. The clinical
indication functionality on electronic prescriptions is still quite
new and not all GPs may ﬁnd it intuitive, easy to use or relevant. A
GP could just use the ﬁrst indication from the drop down menu
throughout the day. This would threaten the validity of the
assigned clinical indications and make the antibiotic use pattern
Antibiotic use patterns in acute respiratory tract infections
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less precise. We believe this problem is virtually impossible to
eliminate, but future studies should be undertaken to improve
understanding of prescriptions with missing and non-speciﬁc
clinical indications.
Implications for future research, policy and practice
Future studies would beneﬁt from differentiating between
daytime and out-of-hours antibiotic use as Huibers et al. have
shown that out-of-hours antibiotic use was high and often
second-line agents were issued, especially among patients >60
years of age.35
Assessing rational antibiotic prescribing is challenging as no
formal quality indicators have been formally developed and
validated in a Danish setting.36, 37 A quality indicator is deﬁned as
a speciﬁc and measurable instrument that can be used to assess
the quality of care provided.38 For optimal impact and validity
context, speciﬁc quality indicators should be developed and
implemented. This process is presently ongoing in Denmark. The
systematic implementation of such valid quality indicators may be
beneﬁcial to future patients by assisting individual clinics striving
to improve care as well as to monitor national surveillance targets
on antibiotic use.39
The number of unspeciﬁc indications is high and an effort to
reduce this group is warranted, bearing in mind that not all cases
issued a prescription may present with a clear site of infection at
the time of consultation. Possible changes might include grouping
of selected clinical indications, such as lower or upper acute
respiratory tract infection, and providing more options for
symptoms or complaints in the clinical indications such as cold
and cough. To more accurately reﬂect the clinical indications for
which antibiotics are prescribed and thus optimize understanding
changes in antibiotic use, a more direct link from medical records
into the electronic prescribing system is warranted.
Conclusions
This study conﬁrms that penicillin V is the most commonly
prescribed antibiotic agent for treatment of patients with an acute
respiratory tract infection in Danish general practice. However, the
high prescribing rate of second-line agents, like macrolides and
extended-spectrum penicillins, could be improved signiﬁcantly.
Future initiatives to promote rational prescribing of antibiotics
should address speciﬁc clinical indications like AOM, acute
rhinosinusitis, and pneumonia.
METHODS
Data sources
All Danish citizens who redeemed an antibiotic prescription (ATC J01, see
below for details) between July 1st 2012 to June 31st 2013 were included.
This 1-year study period was chosen to ensure a coherent winter season
with its corresponding inﬂuenza peak.40
National data on use of antibiotic therapy in Denmark was extracted
from the Danish National Prescription Database.41 This registry contains
complete information on all prescriptions redeemed by Danish residents at
outpatient pharmacies from January 1st 1995 onwards. Antibiotics are only
available by prescription and purchased solely in pharmacies in Denmark.
For each redeemed prescription, the registry contains information on the
following variables relevant to this study: provider practice identiﬁcation
number (encrypted), type of antibiotic, patient age and gender, as well as
clinical indication.
Clinical indications are provided by the electronic prescription system.
As such they are not directly linked to the International Classiﬁcation of
Primary health Care (ICPC-2) coding system used in the GPs medical
records. The GP must select an appropriate clinical indication from a pre
speciﬁed drop down list or enter a free text indication prior to signing of
an antibiotic.
Antibiotic agents were classiﬁed according to the anatomical therapeu-
tic chemical (ATC) index (J01 antibacterial agents for systemic use), down
to 5th level; chemical substance.42
The Danish Civil Registration System43 contains data on all Danish
residents through an individual identiﬁer (encrypted), which allowed us to
keep track of all study subjects.
General practice providers were identiﬁed by the unique identiﬁers for
general practitioners (encrypted), obtained from Statens Serum Institute, to
distinguish GP prescriptions from the entire primary care sector, which also
includes other medical providers such as ear-nose-throat specialist, dentist
etc.40 All information on patient and prescriber level was encrypted.
Statistikbanken.dk, a service from the Statistics Danmark, was used to
determine population size in total and the included age groups.
During the study period (2012–2013), the Danish national guideline11 on
antibiotic use recommended penicillin V as empirical ﬁrst choice for AOM,
acute tonsillitis, acute rhinosinusitis, and pneumonia. In case of penicillin
allergy, a macrolide was recommended. The recommendation for AECOPD
was co-amoxicillin. In case of penicillin allergy, a tetracycline was
recommended. Uncomplicated acute bronchitis is considered a self-
limiting disease and no antibiotic is recommended.
We assumed that recommended empirical ﬁrst-line treatment should
account for at least 80% of prescriptions in order to adhere to guidelines.44
No speciﬁc guidance regarding diagnostics were included, however a
general recommendation regarding use of C-reactive protein was adopted
in general practice (the C-reactive protein speedometer).45
Analyses
A dataset consisting of clinical indications and antibiotic prescriptions was
created by merging datasets by their unique practice identiﬁcation
numbers.The following six age groups for each speciﬁc indication were
used;40 <5 years; 5–14 years; 15–44 years; 45–64 years; 65–74 years, 75+
years.
When assessing the clinical indications for antibiotic prescribing, we
chose to include the full range of acute respiratory tract infections; all R
codes in the International Classiﬁcation of Primary Care, second edition.46
As a result, both upper and lower respiratory tract infections were
included. Furthermore we chose to include AOM to the group of
respiratory tract infections in primary care. This was due to the fact that
the clinical picture of AOM rarely presents as an isolated disease entity, but
most often is accompanied by additional common cold symptoms.
The clinical indicators on the most common acute respiratory tract
infections in primary care were grouped and analyzed: AOM, acute
tonsillitis, acute rhinosinusitis, acute bronchitis, pneumonia, and AECOPD.
Descriptive analyses of antibiotic use were performed, such as percen-
tages, cumulated percentages, no. of treatments per 1000 inhabitants for
each acute respiratory tract infection.
In addition, the accordance of GPs’ antibiotic management of patients
with acute respiratory tract infections was assessed by comparing to
national guidelines.11 Danish national guidelines on antibiotic use
recommends narrow-spectrum penicillin (penicillin V) as ﬁrst-line agent
for most respiratory cases, except AECOPD, where the recommendation in
2012–2013 was co-amoxicillin. All calculations were done in SAS version
9.3 (Cary, NC, USA).
Ethics
The study was approved by the Danish Data Protection Agency (J.nr. 2012-
41-0159). According to Danish law, no approval from an ethics committee
is required for strictly registry based studies.
Data availability
All relevant data are available from the authors, however Danish law on
data protection prohibits access to raw data.
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